Abstract: An implantable cardiac stimulation lead system for use with an implantable stimulation device includes at least a pair of conductors, braided together and extending between proximal and distal ends and co-extruded with flexible resilient insulation material. Each conductor may be a multi-strand cable composed of MP35N or DFT and have its outer peripheral surfaces coated with insulative material. An electrical connector is coupled to the proximal end of the lead system for connection with a stimulation device and includes terminals electrically connected to the conductors. The proximal connector is thereby electrically coupled to a distal tip electrode and to at least one electrode proximally spaced from the distal tip electrode. The lead system may include an elongated tubular lead body of flexible resilient insulative material having a longitudinally extending lumen for receiving a stylet for aid in implanting the lead system. Alternatively, an introducer sheath may be employed for implantation.
Abstract: A medical device delivers a therapy to a patient. The medical device or another device may periodically determine an activity level of the patient, and associate each determined activity level with a current therapy parameter set. A value of at least one activity metric is determined for each of a plurality of therapy parameter sets based on the activity levels associated with that therapy parameter set. A list of the therapy parameter sets is presented to a user, such as a clinician, for evaluation of the relative efficacy of the therapy parameter sets. The list may be ordered according to the one or more activity metric values to aid in evaluation of the therapy parameter sets. Where values are determined for a plurality of activity metrics, the list may be ordered according to the one of the activity metrics selected by the user.
Abstract: A method of using a small implantable stimulator(s) with at least two electrodes small enough to have the electrodes located adjacent to the vagus nerve. The small stimulator provides a means of stimulating the vagus nerve when desired, and may be implanted via a minimal surgical procedure.
Abstract: A neuro-stimulation system and method are provided which can monitor EKG signals and provide electrical stimulation. The system comprises a stimulation lead having at least one stimulating electrode on the lead and an IPG having a case and connectors. The connectors can mechanically and electrical connect to the lead and to the at least one stimulating electrode and an EKG electrode can be placed on the stimulating lead. The IPG case may be used variously as an EKG electrode, as well as an indifferent electrode. Alternatively or additionally, a separate, second lead having a second EKG electrode may be connected to the IPG. This second EKG electrode may also double in function as a stimulation electrode.
Abstract: A heart assist device, for example a left ventricular assist device (LVAD) including a blood pump, is controlled on the basis of a ratio of the pump's speed and the patient's heart rate. The patient's activity and a required cardiac assist level can be defined via the heart beat rate of the patient and a rotational speed of the LVAD pump. Controlling the pump of the heart assist device based on the pump speed and the patient's heart rate enables the heart assist device to respond to changes in the patient's activity level.
Abstract: An object is to provide an electrode member for retina stimulation which can form an actually transmitted image without pressing the retina in an excessively broad range and to provide an artificial retina device using the electrode member. An electrode member includes electrodes disposed in a shape of a vertical and horizontal matrix, a support holding each electrode at a predetermined position, and a fixing pin fixing four corners of the support to a sclera. Each electrode projects in the shape of a needle from an opposed face of the support toward a retina. The fixing pin is provided with a positioning projection allowing a distal end of each electrode to come into contact with retinal bipolar cells and limiting the overall opposed face to come into contact with a retina when the support is fixed to the retina.
Abstract: A remotely programmable infusion system. The remotely programmable infusion system comprises a memory for storing a programmable protocol and a remote communication port for sending a voice signal to a remote touch-tone transceiver and for receiving a remote programming signal from the remote touch-tone transceiver. The remotely programmable infusion system also comprises a voice storage unit for storing the voice signal. The remotely programmable infusion system further comprises a processor, coupled to the remote communication port, to the voice storage unit, and to the memory, for accessing the voice signal from the voice storage unit and the programmable protocol from the memory, and for processing the programmable protocol in response to receiving the remote programming signal.
Abstract: Introducing one or more stimulating drugs to the brain and/or applying electrical stimulation to the brain is used to treat movement disorders. At least one implantable system control unit (SCU) produces electrical pulses delivered via electrodes implanted in the brain and/or drug infusion pulses delivered via a catheter implanted in the brain. The stimulation is delivered to targeted brain structures to adjust the activity of those structures. In some embodiments, one or more sensed conditions are used to adjust stimulation parameters.
Type:
Grant
Filed:
May 2, 2003
Date of Patent:
December 19, 2006
Assignee:
Advanced Bionics Corporation
Inventors:
Todd K Whitehurst, James P McGivern, Kelly H McClure
Abstract: A device for reducing noise in signals having successive substantially repetitive portions, comprising: an iterative averager operative to superimpose and average said substantially repetitive portions to produce a running average thereof, and an iteration ender comprising a noise analyzer for determining a noise level in said running average and ending operation of said iterative averager when said noise level reaches a predetermined level. Also, a method of obtaining an indication of ischemia in a patient using an ECG signal therefrom, the method comprising: extracting an ECG signal over a duration, extracting from said ECG signal a series of QRS complexes over said duration, extracting high frequency components of said QRS complexes, analyzing said high frequency components over said duration for at least one of a predetermined quality, and inferring from said predetermined quality an indication of ischemia.
Type:
Grant
Filed:
December 28, 2000
Date of Patent:
December 19, 2006
Assignee:
BSP Biological Signal Processing Ltd.
Inventors:
Amir Beker, Assaf Hasson, Tamir Ben David
Abstract: Time-varying spatial signals are detected by accelerometers mounted within the patient. The signals, representative of the actual 3-D trajectory of the patient, are compared with information representative of expected trajectories retrieved from memory to identify a current patient posture, which may be either a dynamic posture such as walking or running or a change in posture such as rising from a seated position to a standing position. In this manner, a change in posture of the patient is identified based upon a full 3-D trajectory, rather than merely the orientation of the patient at the beginning and the end of the change in posture. In an example described herein, the implantable device stores information representative of expected 3-D trajectories in the form of pre-calculated comparison matrices derived from orthonormal kernels employing Laguerre functions or Lagrange functions.
Type:
Grant
Filed:
December 23, 2002
Date of Patent:
December 12, 2006
Assignee:
Pacesetter, Inc.
Inventors:
Steve Koh, Mark W. Kroll, Euljoon Park, Gene A. Bornzin
Abstract: Time-varying spatial signals are detected by accelerometers mounted within the patient. The signals, representative of the actual 3-D trajectory of the patient, are compared with information representative of expected trajectories retrieved from memory to identify a current patient posture, which may be either a dynamic posture such as walking or running or a change in posture such as rising from a seated position to a standing position. In this manner, a change in posture of the patient is identified based upon a full 3-D trajectory, rather than merely the orientation of the patient at the beginning and the end of the change in posture. In an example described herein, the implantable device stores information representative of expected 3-D trajectories in the form of pre-calculated comparison matrices derived from orthonormal kernels employing Laguerre functions or Lagrange functions.
Type:
Grant
Filed:
December 23, 2002
Date of Patent:
December 12, 2006
Assignee:
Pacesetter, Inc.
Inventors:
Steve Koh, Mark W. Kroll, Euljoon Park, Gene A. Bornzin
Abstract: A system and method for providing collection and analysis of patient information for use in automated patient care. One or more physiological measures relating to individual patient information recorded on a substantially continuous basis are collected. Each of the one or more physiological measures collected at substantially the same time as a set of physiological measures are received. The physiological measures set are stored into a patient care record for an individual patient into a database. One or more of the physiological measures in the patient care record are retrieved from the database. The retrieved physiological measures are analyzed relative to one or more other physiological measures to determine a patient status indicator.
Abstract: Described are devices and methods for treating degenerative, congestive heart disease and related valvular dysfunction. Percutaneous and minimally invasive surgical tensioning structures offer devices that mitigate changes in the ventricular structure (i.e., remodeling) and deterioration of global left ventricular performance related to tissue damage precipitating from ischemia, acute myocardial infarction (AMI) or other abnormalities. These tensioning structures can be implanted within various major coronary blood-carrying conduit structures (arteries, veins and branching vessels), into or through myocardium, or into engagement with other anatomic structures that impact cardiac output to provide tensile support to the heart muscle wall which resists diastolic filling pressure while simultaneously providing a compressive force to the muscle wall to limit, compensate or provide therapeutic treatment for congestive heart failure and/or to reverse the remodeling that produces an enlarged heart.
Type:
Grant
Filed:
October 11, 2002
Date of Patent:
December 5, 2006
Assignee:
Extensia Medical, Inc.
Inventors:
Suresh Pai, Nicanor Domingo, James G. Whayne
Abstract: An IMD includes a variable sense amplifier that can be adjusted to counteract the variability created in EGM's due to lead maturation. The effects of lead maturation are either predictively assumed or individually assessed on a given patient. The sense amplifier is then adjusted to assure positive identification of desired events and eliminate unwanted events.
Abstract: Methods, systems and computer program products for cardiac pacing are provided. For pacing using biventricular synchronization in a patient, a first stimulation signal is applied to a first region of a heart of the patient at a first time and a second stimulation signal applied to a second region of the heart of the patient at a second time to provide biventricular synchronization stimulation of the heart. Cardiac function of the patient associated with application of the first and the second stimulation signals is sensed and a timing relationship of the first stimulation signal to the second stimulation signal is adjusted based on the sensed cardiac function.
Abstract: A cardiac stimulation device and method discriminates sinus events from non-sinus events and provide a uniquely prescribed response upon detection of a specific event.
Type:
Grant
Filed:
March 28, 2002
Date of Patent:
November 21, 2006
Assignee:
Pacesetter, Inc.
Inventors:
Nabil A. Mouchawar, Elia Arambula Mouchawar, Gabriel A. Mouchawar
Abstract: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.
Abstract: A device and method for programming an implantable pulse generator. In one embodiment, commands are entered designating implantable pulse generator programming variables into programmer memory. At least some of the commands are transformed into an executable macro. The macro is stored in the programmer memory. The macro is executed to transmit the programming variables to the implantable pulse generator.
Abstract: A heart state monitor method is proposed. The physiologic parameter of a life body is measured and then preformed by Fourier transform analysis. Next, the frequency domain data of the physiologic parameter are converted into a power spectral density (PSD). A heart beat noise index of the life body is then obtained according to the PSD. Finally, the heart state of the life body is diagnosed according to the heart beat noise index. The heart beat noise index may be quickly discriminated to let the life body and medical staffs grasp the current heart state of the life body at any time.
Type:
Grant
Filed:
January 17, 2003
Date of Patent:
November 14, 2006
Inventors:
Kuo-Yuan Chang, Kuo-Fu Chang, Chi Fang Yeh
Abstract: A system for collection and analysis of patient information for automated remote patient care is presented. A medical device adapted to be implanted for an individual patient regularly records and stores measures sets containing individual measures which each relate to patient information. A database collects one or more patient care records organized to include a plurality of the collected measures sets, and stores the collected measures set into a patient care record for the individual patient within a database. A server periodically receives a set of the collected measures from the medical device adapted to be implanted, and analyzes one or more of the collected measures sets in the patient care record for the individual patient relative to one or more other collected measures sets stored in the database server to determine a patient status indicator.